Brief: Sandoz Files Antitrust Litigation Against Amgen In The US

Sandoz AG

14/04/2025 06:02

April 14 (Reuters) -

SANDOZ FILES ANTITRUST LITIGATION AGAINST AMGEN REGARDING PATIENT ACCESS TO ETANERCEPT BIOSIMILAR IN THE US

SANDOZ GROUP AG - FILES ANTITRUST LAWSUIT AGAINST AMGEN IN US

SANDOZ GROUP AG - ALLEGES AMGEN BLOCKED BIOSIMILAR COMPETITION

SANDOZ GROUP AG - SEEKS INJUNCTION TO PREVENT AMGEN FROM BLOCKING BIOSIMILAR COMPETITION

Source text: ID:nGNXnrD9Y

Further company coverage: AMGN.O

 ((Reuters.Briefs@thomsonreuters.com;))